Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis

NCT02555969 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT02555969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02555969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis
Lead sponsor
Tufts Medical Center
Phase
Observational
Overall status
Completed
Start date
August 31, 2015
Completion date
August 31, 2020
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, primary amyloidosis